Skip to main content

Ɔmon Tɛrapi fɔ Brɔst Kansa: Lɛ Wi Tɔk Bɔt Dis

Ɔmon Tɛrapi fɔ Brɔst Kansa: Lɛ Wi Tɔk Bɔt Dis

If yu ɔ pɔsin we yu sabi dɔn gɛt bɔdi kansa, yu go mɔs dɔn yɛri di wɔd ‘ɔmon tɛrapi’. Sɔntɛnde, we yu yɛri dis nem, dat kin mek yu fred smɔl ɛn want fɔ no mɔ. Wetin i rili min? Yu tink se i denja? Wetin i de du? Lɛ wi tɔk bɔt ɔl dis insay wan rili simpul ɛn fayn fayn we tide.

Wetin na dis ɔmon tritmɛnt?

Fɔ tɔk am simpul wan, ɔmon tɛrapi na tritmɛnt we rili fayn fɔ sɔm kayn bɔdi kansa. Bɔt dɛn nɔ kin gi am fɔ ɔl di bɔdi kansa. I impɔtant pas ɔl fɔ kansa dɛn we gɛt ɔmon riseptɔ-pɔzitiv (HR+) .

Tink bɔt am, tu kayn ɔmon dɛn de we dɛn kin mek na wi bɔdi we dɛn kɔl Ɛstrojen ɛn Prɔjɛstɛron. Sɔm bɔdi kansa sɛl dɛn tan lɛk smɔl plant. Jɔs lɛk aw plant nid wata, na so dɛn kansa sɛl ya nid dɛn tu ɔmon ya fɔ mek dɛn gro ɛn skata. Wi de kɔl dis HR+ kansa. Fɔ tɔk smɔl, tu pan ɔl tri pipul dɛn we gɛt bɔdi kansa gɛt dis kayn kansa.

Yu go dɔn si tin dɛn lɛk dis na yu kansa ripɔt:

  • εstrojen rεsεptכr positifu (ER+) .
  • Projesteron rεsεptכr positifu (PR+) .

Kansa kin bi pɔsitiv fɔ wan ɔ ɔl tu pan dɛn tin ya. ER+ na di kayn we we dɛn kin yuz mɔ.

So wetin dis ɔmon tɛrapi de du rili simpul. I de wok tu men we dɛn:

1. I de blok di כmon dεm (εstrojen εn projεstεron) we di kεnsar sεl dεm nid. I tan lɛk se yu blok di wata paip we de gi di plant.

2. I de ridyus di εstrojen lεvεl na di bכdi. dis de mek di kεnsar sεl dεm nכ gεt di "nutrishכn" we dεn nid fכ gro εn i de stכp dεm fכ gro.

Impɔtant tin na dat, ɔmon tritmɛnt fɔ brɔst kansa difrɛn ɔl frɔm ɔmon tritmɛnt fɔ di simptom dɛm we pɔsin kin gɛt we i de menɔpauz, we kin wok bay we i de mek di ɔmon lɛvɛl go ɔp. Di tritmɛnt fɔ kansa kin du di kɔmɔn tin.

Wetin mek dɛn kin gi dis ɔmon tritmɛnt?

Di wan dɛn we de stɔdi bɔt kansa kin se dis tritmɛnt de pan difrɛn tin dɛn.

  • Fɔ ridyus di risk fɔ gɛt kansa: Dɛn kin gi dis tritmɛnt to pipul dɛn we gɛt ay risk fɔ gɛt bɔdi kansa, fɔ ɛgzampul, di wan dɛn we gɛt jɛnɛtik muteshon lɛk `BRCA1` ɛn `BRCA2`, fɔ mek dɛn nɔ gɛt kansa.
  • insay di kes fכ DCIS: kכntrol di growth fכ di εli stej brεst kεnsar we dεn kכl `Ductal Carcinoma In Situ (DCIS).`
  • Bifo dɛn du di ɔpreshɔn (Neoadjuvant Therapy):Dɛn kin gi dis tritmɛnt bifo dɛn du di ɔpreshɔn fɔ mek di tumbu smɔl ɛn mek di ɔpreshɔn izi.
  • Adjuvant Therapy: Dis na di kayn tritmɛnt we dɛn kin yuz mɔ. Dɛn kin gi am afta dɛn dɔn ɔpreshɔn fɔ pul di kansa, fɔ mek di kansa nɔ kam bak ɔ fɔ mek kansa nɔ kam na di ɔda bɔdi.
  • We di kansa dɔn skata (Metastatic Breast Cancer): If di kansa dɔn spre to ɔda pat dɛn na di bɔdi, dɛn kin yuz dis tritmɛnt fɔ kɔntrol aw dɛn sɛl dɛn de gro.

Wetin na di men kayn ɔmon tritmɛnt?

Bɔku kayn ɔmon tritmɛnt dɛn de. Yu dɔktɔ go disayd us tritmɛnt go fayn fɔ yu bay tin dɛn lɛk yu ej, if yu dɔn go tru menopause, ɛn di kayn kansa. Lɛ wi luk di men kayn dɛn.

Tayp fɔ di Tɛrapi Aw i de wok & Ɛgzampul dɛn
Aromatase Inhibitor dɛn we de mek pɔsin nɔ ebul fɔ du sɔntin Dɛn kin gi dɛn tin ya mɔ to uman dɛn we dɔn pas 40 ia . Dɛn kin stɔp di bɔdi fɔ mek i nɔ mek ɛstrojen. Ɛgzampul dɛn: Lɛtrozɔl, Anastrozɔl, Ɛksimɛstan.
SERMs (Sεlektiv εstrojen rεsεptor mכdulεtכr dεm) . Dɛn mɛrɛsin ya kin mek di ɔmon we dɛn kɔl ɛstrojen nɔ atak di kansa sɛl dɛn. uman dεm we de bifo εn afta uman dεn kin yuz dεm . Di mɛrɛsin we dɛn kin yuz mɔ na Tamoxifen .
Ovarian Fɔnkshɔn Sɔpreshɔn Dɛn kin gi dɛn tin ya to uman dɛn we nɔ rich 18 ia yet . Dɛn kin stɔp fɔ mek di ɛstrojen kɔmɔt na di ovaria fɔ sɔm tɛm. Dɛn kin gi dɛn tin ya as injɛkshɔn. Ɛgzampul dɛn: Goserelin, Leuprolide.
SERD dεm (Sεlektiv εstrojen rεsεptor dכwnrεgulεtכr dεm) .dis dεm sכm kayn we lεk SERM dεm, bכt dεn mכr pawa fכ blכk εn pwεl di εstrojen rεsεpכta dεm. Fɔ ɛgzampul: Fulvestrant.

Aw fɔ gɛt dis tritmɛnt?

Bɔrku tɛm, dɛn kin gi dis tritmɛnt as pil wae yu kin tek ɛvride. Sɔm mɛrɛsin dɛn de bak as wata. Sɔm, lɛk mɛrɛsin dɛn we de stɔp di ovaria fɔ wok, dɛn kin gi am as injɛkshɔn na yu dɔktɔ in ɔfis wan tɛm insay di mɔnt. Dipen pan yu sik, yu kin nid fɔ tek dis tritmɛnt fɔ lɔng tɛm, lɛk 5 ɔ 10 ia .

Ɛni sayd ɛfɛkt de fɔ dis tritmɛnt?

Jɔs lɛk ɛni tritmɛnt, sɔm sayd ɛfɛkt kin apin wit dis tritmɛnt. Bɔt nɔto ɔlman kin gɛt dɛn, ɛn nɔto ɔlman kin fil dɛn di sem we . Sɔm pipul dɛn nɔ kin gɛt ɛni prɔblɛm. Di sayd ɛfɛkt dɛm we kin apin pas ɔl na:

  • Fɔ fil taya ɛn taya.
  • Hot flash dɛn we de shayn.
  • Jɔyn ɛn mɔsul dɛn de pen ɔ stiffness.
  • Di want fɔ du mami ɛn dadi biznɛs we de go dɔŋ.
  • Di we aw yu de fil kin chenj ɔltɛm.
  • Nɔs ɛn vɔmit.
  • Di vagina dray we de dray.
  • We yu de gɛt mɔ wet.

If yu de gɛt ɛni wan pan dɛn tin ya we nɔ fayn, nɔ shem ɔ fred fɔ tɔk to yu dɔktɔ . Way ɛn mɛrɛsin de wae kin ɛp fɔ kɔntrol bɔrku pan dɛn sayd ɛfɛkt ya. So nɔ sɔfa yu wan.

Di bɛnifit ɛn sakrifays we ɔmon tɛrapi gɛt

Wan pan di big big bɛnifit dɛm fɔ dis tritmɛnt na dat i de tɔch di kayn bɔdi kansa (ER+) we kɔmɔn pas ɔl. Dɔn bak, dɛn kin gi dis tritmɛnt togɛda wit ɔda tritmɛnt dɛn lɛk kemotɛrapi ɛn targeted therapy.

Risach dɔn sho klia wan se ɔmon tritmɛnt kin rili ridyus di risk fɔ gɛt kansa bak ɛn i kin mek di sikman dɛn layf lɔng, we kin mek i bi wan tritmɛnt we kin rili wok fayn ɛn we impɔtant.

Yu tink se kemotɛrapi ɔ ɔmon tɛrapi bɛtɛ?

Dis na lɛk fɔ aks se, "Uswan bɛtɛ, skru drayva ɔ hama?" Dɛn na tu difrɛn tin dɛn we dɛn kin yuz fɔ du difrɛn tin dɛn. Kimotɛrapi na pawaful tritmɛnt we de kil di sɛl dɛn we de sheb kwik kwik wan. Ɔmon tɛrapi na tritmɛnt we de tɔch ɔl di kansa sɛl dɛn we de dipen pan ɔmon. Sɔntɛnde yu kin nid ɔl tu, ɛn sɔntɛnde yu kin jɔs nid wan. Yu dɔktɔ go disayd uswan go fayn fɔ yu.

Wetin a go du if a nɔ lɛk dis tritmɛnt?

Dis na kwɛstyɔn we rili impɔtant. Mɛmba se wetin yu want ɛn wetin yu tink rili impɔtant we i kam pan tritmɛnt. Yu dɔktɔ go tɛl yu fɔ gɛt tritmɛnt plan bay ɔltin frɔm di kayn kansa we yu gɛt, yu ɔl wɛl bɔdi, yu layf, ɛn wetin yu lɛk.

If yu gɛt ɛnitin fɔ fred, dawt, ɔ nɔ lɛk bɔt ɔmon tritmɛnt, nɔ shek fɔ tɔk opin wan to yu dɔktɔ bɔt am . Di tin we impɔtant pas ɔl na fɔ tɔk bɔt di bɛnifit ɛn bad tin dɛn we di tritmɛnt gɛt, wetin fɔ du if i gɛt sayd ɛfɛkt, ɛn if ɔda tin dɛn de we yu kin du, ɛn disayd fɔ du sɔntin we go ɛp yu.

Mɛsej we dɛn kin kɛr go na os

  • Ɔmon tɛrapi na tritmɛnt we rili fayn fɔ ɔmon (ɛstrojen, prɔjɛstɛron)-dipɛndent (HR+) brɔst kansa.
  • Dis kin mek di kansa sɛl dɛn nɔ gɛt ɔmon ɔ i kin mek di ɔmon dɛn we de na di bɔdi nɔ bɔku.
  • Dɛn kin yuz dis bifo ɔ afta di ɔpreshɔn fɔ ridyus di risk fɔ gɛt kansa ɔ fɔ kɔntrol kansa we dɔn skata.
  • Sɔm bad bad tin dɛn kin apin, bɔt dɛn kin ebul fɔ kɔntrol dɛn. I impɔtant fɔ tɔk to yu dɔktɔ bɔt ɛnitin we nɔ fayn fɔ yu.
  • Tɔk bɔt ɛni kwɛstyɔn ɔ tin we de mɔna yu bɔt tritmɛnt wit yu dɔktɔ ɛn disayd fɔ du di bɛst tin togɛda.

Brest Kansa, Ɔmon Tɛrapi, Ɔmon Tɛrapi, ER-positiv, Tamoxifen, Kansa Tritmɛnt, Uman dɛn Wɛlbɔdi

Frequently Asked Questions (FAQ)

Yu tink se kemotɛrapi ɔ ɔmon tɛrapi bɛtɛ?

Dis na lɛk fɔ aks se, "Uswan bɛtɛ, skru drayva ɔ hama?" Dɛn na tu difrɛn tin dɛn we dɛn kin yuz fɔ du difrɛn tin dɛn. Kimotɛrapi na pawaful tritmɛnt we de kil di sɛl dɛn we de sheb kwik kwik wan. Ɔmon tɛrapi na tritmɛnt we de tɔch ɔl di kansa sɛl dɛn we de dipen pan ɔmon. Sɔntɛnde yu kin nid ɔl tu, ɛn sɔntɛnde yu kin jɔs nid wan. Yu dɔktɔ go disayd uswan go fayn fɔ yu.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 6 + 4 =
Ɔmon Tɛrapi fɔ Brɔst Kansa: Lɛ Wi Tɔk Bɔt Dis

Ɔmon Tɛrapi fɔ Brɔst Kansa: Lɛ Wi Tɔk Bɔt Dis

If yu ɔ pɔsin we yu sabi dɔn gɛt bɔdi kansa, yu go mɔs dɔn yɛri di wɔd ‘ɔmon tɛrapi’. Sɔntɛnde, we yu yɛri dis nem, dat kin mek yu fred smɔl ɛn want fɔ no mɔ. Wetin i rili min? Yu tink se i denja? Wetin i de du? Lɛ wi tɔk bɔt ɔl dis insay wan rili simpul ɛn fayn fayn we tide.

Wetin na dis ɔmon tritmɛnt?

Fɔ tɔk am simpul wan, ɔmon tɛrapi na tritmɛnt we rili fayn fɔ sɔm kayn bɔdi kansa. Bɔt dɛn nɔ kin gi am fɔ ɔl di bɔdi kansa. I impɔtant pas ɔl fɔ kansa dɛn we gɛt ɔmon riseptɔ-pɔzitiv (HR+) .

Tink bɔt am, tu kayn ɔmon dɛn de we dɛn kin mek na wi bɔdi we dɛn kɔl Ɛstrojen ɛn Prɔjɛstɛron. Sɔm bɔdi kansa sɛl dɛn tan lɛk smɔl plant. Jɔs lɛk aw plant nid wata, na so dɛn kansa sɛl ya nid dɛn tu ɔmon ya fɔ mek dɛn gro ɛn skata. Wi de kɔl dis HR+ kansa. Fɔ tɔk smɔl, tu pan ɔl tri pipul dɛn we gɛt bɔdi kansa gɛt dis kayn kansa.

Yu go dɔn si tin dɛn lɛk dis na yu kansa ripɔt:

  • εstrojen rεsεptכr positifu (ER+) .
  • Projesteron rεsεptכr positifu (PR+) .

Kansa kin bi pɔsitiv fɔ wan ɔ ɔl tu pan dɛn tin ya. ER+ na di kayn we we dɛn kin yuz mɔ.

So wetin dis ɔmon tɛrapi de du rili simpul. I de wok tu men we dɛn:

1. I de blok di כmon dεm (εstrojen εn projεstεron) we di kεnsar sεl dεm nid. I tan lɛk se yu blok di wata paip we de gi di plant.

2. I de ridyus di εstrojen lεvεl na di bכdi. dis de mek di kεnsar sεl dεm nכ gεt di "nutrishכn" we dεn nid fכ gro εn i de stכp dεm fכ gro.

Impɔtant tin na dat, ɔmon tritmɛnt fɔ brɔst kansa difrɛn ɔl frɔm ɔmon tritmɛnt fɔ di simptom dɛm we pɔsin kin gɛt we i de menɔpauz, we kin wok bay we i de mek di ɔmon lɛvɛl go ɔp. Di tritmɛnt fɔ kansa kin du di kɔmɔn tin.

Wetin mek dɛn kin gi dis ɔmon tritmɛnt?

Di wan dɛn we de stɔdi bɔt kansa kin se dis tritmɛnt de pan difrɛn tin dɛn.

  • Fɔ ridyus di risk fɔ gɛt kansa: Dɛn kin gi dis tritmɛnt to pipul dɛn we gɛt ay risk fɔ gɛt bɔdi kansa, fɔ ɛgzampul, di wan dɛn we gɛt jɛnɛtik muteshon lɛk `BRCA1` ɛn `BRCA2`, fɔ mek dɛn nɔ gɛt kansa.
  • insay di kes fכ DCIS: kכntrol di growth fכ di εli stej brεst kεnsar we dεn kכl `Ductal Carcinoma In Situ (DCIS).`
  • Bifo dɛn du di ɔpreshɔn (Neoadjuvant Therapy):Dɛn kin gi dis tritmɛnt bifo dɛn du di ɔpreshɔn fɔ mek di tumbu smɔl ɛn mek di ɔpreshɔn izi.
  • Adjuvant Therapy: Dis na di kayn tritmɛnt we dɛn kin yuz mɔ. Dɛn kin gi am afta dɛn dɔn ɔpreshɔn fɔ pul di kansa, fɔ mek di kansa nɔ kam bak ɔ fɔ mek kansa nɔ kam na di ɔda bɔdi.
  • We di kansa dɔn skata (Metastatic Breast Cancer): If di kansa dɔn spre to ɔda pat dɛn na di bɔdi, dɛn kin yuz dis tritmɛnt fɔ kɔntrol aw dɛn sɛl dɛn de gro.

Wetin na di men kayn ɔmon tritmɛnt?

Bɔku kayn ɔmon tritmɛnt dɛn de. Yu dɔktɔ go disayd us tritmɛnt go fayn fɔ yu bay tin dɛn lɛk yu ej, if yu dɔn go tru menopause, ɛn di kayn kansa. Lɛ wi luk di men kayn dɛn.

Tayp fɔ di Tɛrapi Aw i de wok & Ɛgzampul dɛn
Aromatase Inhibitor dɛn we de mek pɔsin nɔ ebul fɔ du sɔntin Dɛn kin gi dɛn tin ya mɔ to uman dɛn we dɔn pas 40 ia . Dɛn kin stɔp di bɔdi fɔ mek i nɔ mek ɛstrojen. Ɛgzampul dɛn: Lɛtrozɔl, Anastrozɔl, Ɛksimɛstan.
SERMs (Sεlektiv εstrojen rεsεptor mכdulεtכr dεm) . Dɛn mɛrɛsin ya kin mek di ɔmon we dɛn kɔl ɛstrojen nɔ atak di kansa sɛl dɛn. uman dεm we de bifo εn afta uman dεn kin yuz dεm . Di mɛrɛsin we dɛn kin yuz mɔ na Tamoxifen .
Ovarian Fɔnkshɔn Sɔpreshɔn Dɛn kin gi dɛn tin ya to uman dɛn we nɔ rich 18 ia yet . Dɛn kin stɔp fɔ mek di ɛstrojen kɔmɔt na di ovaria fɔ sɔm tɛm. Dɛn kin gi dɛn tin ya as injɛkshɔn. Ɛgzampul dɛn: Goserelin, Leuprolide.
SERD dεm (Sεlektiv εstrojen rεsεptor dכwnrεgulεtכr dεm) .dis dεm sכm kayn we lεk SERM dεm, bכt dεn mכr pawa fכ blכk εn pwεl di εstrojen rεsεpכta dεm. Fɔ ɛgzampul: Fulvestrant.

Aw fɔ gɛt dis tritmɛnt?

Bɔrku tɛm, dɛn kin gi dis tritmɛnt as pil wae yu kin tek ɛvride. Sɔm mɛrɛsin dɛn de bak as wata. Sɔm, lɛk mɛrɛsin dɛn we de stɔp di ovaria fɔ wok, dɛn kin gi am as injɛkshɔn na yu dɔktɔ in ɔfis wan tɛm insay di mɔnt. Dipen pan yu sik, yu kin nid fɔ tek dis tritmɛnt fɔ lɔng tɛm, lɛk 5 ɔ 10 ia .

Ɛni sayd ɛfɛkt de fɔ dis tritmɛnt?

Jɔs lɛk ɛni tritmɛnt, sɔm sayd ɛfɛkt kin apin wit dis tritmɛnt. Bɔt nɔto ɔlman kin gɛt dɛn, ɛn nɔto ɔlman kin fil dɛn di sem we . Sɔm pipul dɛn nɔ kin gɛt ɛni prɔblɛm. Di sayd ɛfɛkt dɛm we kin apin pas ɔl na:

  • Fɔ fil taya ɛn taya.
  • Hot flash dɛn we de shayn.
  • Jɔyn ɛn mɔsul dɛn de pen ɔ stiffness.
  • Di want fɔ du mami ɛn dadi biznɛs we de go dɔŋ.
  • Di we aw yu de fil kin chenj ɔltɛm.
  • Nɔs ɛn vɔmit.
  • Di vagina dray we de dray.
  • We yu de gɛt mɔ wet.

If yu de gɛt ɛni wan pan dɛn tin ya we nɔ fayn, nɔ shem ɔ fred fɔ tɔk to yu dɔktɔ . Way ɛn mɛrɛsin de wae kin ɛp fɔ kɔntrol bɔrku pan dɛn sayd ɛfɛkt ya. So nɔ sɔfa yu wan.

Di bɛnifit ɛn sakrifays we ɔmon tɛrapi gɛt

Wan pan di big big bɛnifit dɛm fɔ dis tritmɛnt na dat i de tɔch di kayn bɔdi kansa (ER+) we kɔmɔn pas ɔl. Dɔn bak, dɛn kin gi dis tritmɛnt togɛda wit ɔda tritmɛnt dɛn lɛk kemotɛrapi ɛn targeted therapy.

Risach dɔn sho klia wan se ɔmon tritmɛnt kin rili ridyus di risk fɔ gɛt kansa bak ɛn i kin mek di sikman dɛn layf lɔng, we kin mek i bi wan tritmɛnt we kin rili wok fayn ɛn we impɔtant.

Yu tink se kemotɛrapi ɔ ɔmon tɛrapi bɛtɛ?

Dis na lɛk fɔ aks se, "Uswan bɛtɛ, skru drayva ɔ hama?" Dɛn na tu difrɛn tin dɛn we dɛn kin yuz fɔ du difrɛn tin dɛn. Kimotɛrapi na pawaful tritmɛnt we de kil di sɛl dɛn we de sheb kwik kwik wan. Ɔmon tɛrapi na tritmɛnt we de tɔch ɔl di kansa sɛl dɛn we de dipen pan ɔmon. Sɔntɛnde yu kin nid ɔl tu, ɛn sɔntɛnde yu kin jɔs nid wan. Yu dɔktɔ go disayd uswan go fayn fɔ yu.

Wetin a go du if a nɔ lɛk dis tritmɛnt?

Dis na kwɛstyɔn we rili impɔtant. Mɛmba se wetin yu want ɛn wetin yu tink rili impɔtant we i kam pan tritmɛnt. Yu dɔktɔ go tɛl yu fɔ gɛt tritmɛnt plan bay ɔltin frɔm di kayn kansa we yu gɛt, yu ɔl wɛl bɔdi, yu layf, ɛn wetin yu lɛk.

If yu gɛt ɛnitin fɔ fred, dawt, ɔ nɔ lɛk bɔt ɔmon tritmɛnt, nɔ shek fɔ tɔk opin wan to yu dɔktɔ bɔt am . Di tin we impɔtant pas ɔl na fɔ tɔk bɔt di bɛnifit ɛn bad tin dɛn we di tritmɛnt gɛt, wetin fɔ du if i gɛt sayd ɛfɛkt, ɛn if ɔda tin dɛn de we yu kin du, ɛn disayd fɔ du sɔntin we go ɛp yu.

Mɛsej we dɛn kin kɛr go na os

  • Ɔmon tɛrapi na tritmɛnt we rili fayn fɔ ɔmon (ɛstrojen, prɔjɛstɛron)-dipɛndent (HR+) brɔst kansa.
  • Dis kin mek di kansa sɛl dɛn nɔ gɛt ɔmon ɔ i kin mek di ɔmon dɛn we de na di bɔdi nɔ bɔku.
  • Dɛn kin yuz dis bifo ɔ afta di ɔpreshɔn fɔ ridyus di risk fɔ gɛt kansa ɔ fɔ kɔntrol kansa we dɔn skata.
  • Sɔm bad bad tin dɛn kin apin, bɔt dɛn kin ebul fɔ kɔntrol dɛn. I impɔtant fɔ tɔk to yu dɔktɔ bɔt ɛnitin we nɔ fayn fɔ yu.
  • Tɔk bɔt ɛni kwɛstyɔn ɔ tin we de mɔna yu bɔt tritmɛnt wit yu dɔktɔ ɛn disayd fɔ du di bɛst tin togɛda.

Brest Kansa, Ɔmon Tɛrapi, Ɔmon Tɛrapi, ER-positiv, Tamoxifen, Kansa Tritmɛnt, Uman dɛn Wɛlbɔdi

Frequently Asked Questions (FAQ)

Yu tink se kemotɛrapi ɔ ɔmon tɛrapi bɛtɛ?

Dis na lɛk fɔ aks se, "Uswan bɛtɛ, skru drayva ɔ hama?" Dɛn na tu difrɛn tin dɛn we dɛn kin yuz fɔ du difrɛn tin dɛn. Kimotɛrapi na pawaful tritmɛnt we de kil di sɛl dɛn we de sheb kwik kwik wan. Ɔmon tɛrapi na tritmɛnt we de tɔch ɔl di kansa sɛl dɛn we de dipen pan ɔmon. Sɔntɛnde yu kin nid ɔl tu, ɛn sɔntɛnde yu kin jɔs nid wan. Yu dɔktɔ go disayd uswan go fayn fɔ yu.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 6 + 4 =